signalgroup

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

February 22, 2022 signalgroup

Report Highlights Employer Savings from Increased Employee Access to Biosimilars

February 15, 2022 signalgroup

The Biosimilars Forum Congratulates Dr. Robert Califf on His Confirmation as FDA Commissioner

February 3, 2022 signalgroup

Biosimilars Forum Supports the Negotiated BsUFA III Agreement in Capitol Hill Testimony

January 31, 2022 signalgroup

Juliana M. Reed Named Executive Director of the Biosimilars Forum

October 21, 2021 signalgroup

Biosimilars Forum Member Spotlight: 5 Questions for Samsung Bioepis

October 20, 2021 signalgroup

First Biosimilar to Treat Eye Disease Gains FDA Approval

September 20, 2021 signalgroup

Senator Wyden, fulfill your promise to lower drug costs for Oregonians by increasing access to next generation generics known as biosimilars

September 20, 2021 signalgroup

Senator Carper, fulfill your promise to lower drug costs for Delawareans by increasing access to next generation generics known as biosimilars

September 9, 2021 signalgroup

Biden Administration’s Plan to Lower Prescription Drug Prices Supports Biosimilar Competition, which will Decrease Drug Costs

August 12, 2021 signalgroup

President Biden’s Plan to Lower Drug Prices Highlights Need for Competition from Biosimilars